Publications

Sypek MP, Howell M, Howard K, Wong G, Duncanson E, Clayton PD, et al. Healthcare professional and community preferences in deceased donor kidney allocation: a best‐worst scaling survey. American Journal of Transplantation. 2022;22(3):886-97.

Lim WH, Ooi E, Pilmore HL, Johnson DW, McDonald SP, Clayton P, et al. Interactions between donor age and 12-month estimated glomerular filtration rate on allograft and patient outcomes after kidney transplantation. Transpl Int. 2022;36(10199):10199-1–10.

Hewawasam E, Davies CE, Li Z, Clayton P, Sullivan E, McDonald SP, et al. Determinants of Perinatal Outcomes in Dialyzed and Transplanted Women in Australia. Kidney international reports. 2022;7(6):1318-31.

Dobrijevic ELK, Au EHK, Rogers NM, Clayton PA, Wong G, Allen RDM. Association Between Side of Living Kidney Donation and Post-Transplant Outcomes. Transpl Int. 2022;35(10117):10117-1-77-11.

Yao J, Clayton PA, Wyburn K, Choksi H, Cavazzoni E, Tovmassian D, et al. Paediatric kidney transplants from donors aged 1 year and under: an analysis of the Australian and New Zealand Dialysis and Transplant Registry from 1963 to 2018. Transpl Int. 2021;34(1):118-26.

Wong YHS, Wong G, Johnson DW, McDonald S, Clayton P, Boudville N, et al. Socioeconomic disparity, access to care and patient relevant outcomes after kidney allograft failure. Transpl Int. 2021;34(11):2329-40.

Tang J, Gulyani A, Hewawasam E, McDonald S, Clayton P, Webster AC, et al. Pregnancy outcomes for simultaneous Pancreas–Kidney transplant recipients versus kidney transplant recipients. Clinical Transplantation. 2021;35(1).

Sypek MP, Kausman JY, Watson N, Wyburn K, Holt SG, Hughes P, et al. The Introduction of cPRA and Its Impact on Access to Deceased Donor Kidney Transplantation for Highly Sensitized Patients in Australia. Transplantation. 2021;105(6):1317-25.

Sypek MP, Davies CE, Le Page AK, Clayton P, Hughes PD, Larkins N, et al. Paediatric deceased donor kidney transplant in Australia: A 30-year review—What have paediatric bonuses achieved and where to from here? Pediatr Transplant. 2021;25(6):e14019.

Pei J, Cho Y, See YP, Pascoe EM, Viecelli AK, Francis RS, et al. Impact of deceased donor with acute kidney injury on subsequent kidney transplant outcomes-an ANZDATA registry analysis. PLoS ONE. 2021;16(3 March).

Ng S, Pascoe EM, Johnson DW, Hawley CM, Polkinghorne KR, McDonald S, et al. Center-Effect of Incident Hemodialysis Vascular Access Use: Analysis of a Bi-national Registry. Kidney360. 2021;2(4):674-83.

Montarello NJ, Salehi T, Bate AP, Pisaniello AD, Clayton PA, Teo KSL, et al. Multimodality Tachycardia-Induced Stress Testing Predicts a Low-Risk Group for Early Cardiovascular Mortality After Renal Transplantation. Kidney international reports. 2021;6(1):120-7.

Meade A, Le Leu R, Watson N, Jesudason S, Clayton P, Faull R, et al. Gastrointestinal symptom burden and dietary intake in patients with chronic kidney disease. Journal of Renal Care. 2021;47(4):234-41.

Irish GL, Coates PT, Clayton PA. Association of admission, nadir, and terminal donor creatinine with kidney transplantation outcomes. Kidney international reports. 2021;6(8):2075-83.

Hewawasam E, Davies CE, Gulyani A, Li Z, Clayton PA, Sullivan E, et al. Factors influencing fertility rates in Australian women receiving kidney replacement therapy: analysis of linked Australia and New Zealand Dialysis and Transplant Registry and perinatal data over 22 years. Nephrology Dialysis Transplantation. 2021;37(6):1-10.

Ying T, Shi B, Kelly PJ, Pilmore H, Clayton PA, Chadban SJ. Death after kidney transplantation: An analysis by era and time post-transplant. J Am Soc Nephrol. 2020;31(12):2887-99.

Sypek MP, Hughes P, Holdsworth R, Kanellis J, McDonald S, Clayton PD. Insights into the labelling effect of KDPI reporting: the Australian experience. American Journal of Transplantation. 2020;20(3):870-8.

Sypek MP, Hiho S, Cantwell L, Clayton P, Hughes P, Le Page AK, et al. Human leukocyte antigen eplet mismatches and long-term clinical outcomes in pediatric renal transplantation: A pragmatic, registry-based study. Pediatr Transplant. 2020;24(4).

Rangaswamy D, Guddattu V, Webster AC, Borlace M, Boudville N, Clayton P, et al. Icodextrin use for peritoneal dialysis in Australia: A cohort study using Australia and New Zealand Dialysis and Transplant Registry. Perit Dial Int. 2020;40(2):209-19.

Lo-Cao E, Yao J, Robertson P, Clayton P, Cavazzoni E, Pleass H. Paediatric en bloc kidney transplantation from a donor less than 5 kg. ANZ J Surg. 2020;90(9):1793-4.

Jesudason S, Fitzpatrick A, Gulyani A, Davies CE, Hewawasam E, Clayton PA, et al. Fatherhood and kidney replacement therapy: analysis of the Australian and New Zealand Dialysis and Transplantation (ANZDATA) Registry. Am J Kidney Dis. 2020;76(3):444-6.

Jalalonmuhali M, Carroll RP, Tsiopelas E, Clayton P, Coates PT. Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients. Hum Immunol. 2020;81(7):323-9.

Irish GL, Hesselman P, Pedchenko VK, Clayton PA, Coates PT. The Case. Kidney International. 2020;98(6):1627-8.

Irish GL, Coates PT, Clayton PA. Cancer post kidney transplant: the question of risk. Journal of Nephrology. 2020;33(6):1129-31.

Htay H, Pascoe EM, Hawley CM, Campbell SB, Chapman J, Cho Y, et al. Patient and center characteristics associated with kidney transplant outcomes: a binational registry analysis. Transpl Int. 2020;33(12):1667-80.

Htay H, Cho Y, Pascoe EM, Hawley C, Clayton PA, Borlace M, et al. Multicentre registry data analysis comparing outcomes of culture-negative peritonitis and different subtypes of culture-positive peritonitis in peritoneal dialysis patients. Perit Dial Int. 2020;40(1):47-56.

Hewawasam E, Gulyani A, Davies CE, Sullivan E, Wark S, Clayton PA, et al. Parenthood and pregnancy in Australians receiving treatment for end-stage kidney disease: protocol of a national study of perinatal and parental outcomes through population record linkage. BMJ open. 2020;10(5):1-7.

Gutman T, Tong A, Howell M, Dansie K, Hawley CM, Craig JC, et al. Principles and strategies for involving patients in research in chronic kidney disease: report from national workshops. Nephrology Dialysis Transplantation. 2020;35(9):1585-94.

Gambaro G, Piccoli GB. Nothing will ever be as before. Reflections on the COVID-19 epidemics by nephrologists in eleven countries. J Nephrol. 2020;33(4):633-7.

de la Mata NL, Clayton PA, Kelly PJ, McDonald S, Chadban S, Polkinghorne KR, et al. Survival in living kidney donors: An Australian and New Zealand cohort study using data linkage. Transplantation Direct. 2020;6(3):e533.

Dansie K, Viecelli AK, Pascoe EM, Johnson DW, McDonald S, Clayton P, et al. Novel trial strategies to enhance the relevance, efficiency, effectiveness and impact of nephrology research. Kidney International. 2020;98(3):572-8.

Collins MG, Fahim MA, Pascoe EM, Dansie KB, Hawley CM, Clayton PA, et al. Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation. Trials. 2020;21(1):428-1–19.

Ying T, Wong G, Lim WH, Clayton P, Kanellis J, Pilmore H, et al. Everolimus and Long-Term Clinical Outcomes in Kidney Transplant Recipients: A Registry-based 10-year Follow-up of 5 Randomized Trials. Transplantation. 2019;103(8):1705-13.

Wyld MLR, Morton RL, Clayton P, Wong MG, Jardine M, Polkinghorne K, et al. The impact of progressive chronic kidney disease on health-related quality-of-life: a 12-year community cohort study. Qual Life Res. 2019;28(8):2081-90.

Sypek MP, Dansie KB, Clayton P, Webster AC, McDonald S. Comparison of cause of death between Australian and New Zealand Dialysis and Transplant Registry and the Australian National Death Index. Nephrology. 2019;24(3):322-9.

Sypek M, Ullah S, Hughes P, Clayton P, McDonald S. Examining the increased rates of deceased donor kidney nonutilization in Australia: what has changed? Transplantation. 2019;103(12):2582-90.

Smith G, Gujari D, Russell O, Palmer L, Toews M, Wong G, et al. International travel by Australians for overseas transplantation. Med J Aust. 2019;211(10):460-.

Mogulla MR, Bhattacharjya S, Clayton PA. Risk factors for and outcomes of delayed graft function in live donor kidney transplantation – a retrospective study. Transpl Int. 2019;32(11):1151-60.

Ling JEH, Fink M, Westall G, MacDonald P, Clayton PA, Holdsworth R, et al. Risk Indices in Deceased-donor Organ Allocation for Transplantation: Review from an Australian Perspective. Transplantation. 2019;103(5):875-89.

Lim WH, Johnson DW, McDonald SP, Hawley C, Clayton PA, Jose MD, et al. Impending challenges of the burden of end-stage kidney disease in Australia. Med J Aust. 2019;211(8):374-80.

Irish GL, Chadban S, McDonald S, Clayton PA. Quantifying lead time bias when estimating patient survival in pre-emptive living kidney donor transplantation. Am J Transplant. 2019;19(12):3367-76.

Flabouris K, Chadban S, Ladhani M, Cervelli M, Clayton P. Body mass index, weight-adjusted immunosuppression and the risk of acute rejection and infection after kidney transplantation: a cohort study. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association – European Renal Association. 2019;34(12):2132-43.

Dias BH, Rana AAM, Olakkengil SA, Russell CH, Coates PTH, Clayton PA, et al. Development and implementation of an enhanced recovery after surgery protocol for renal transplantation. ANZ J Surg. 2019;89(10):1319-23.

Clayton PA, McDonald SP, Russ GR, Chadban SJ. Long-term outcomes after acute rejection in kidney transplant recipients: an ANZDATA analysis. J Am Soc Nephrol. 2019;30(9):1697-707.

Clayton PA, Dansie K, Sypek MP, White S, Chadban S, Kanellis J, et al. External validation of the US and UK kidney donor risk indices for deceased donor kidney transplant survival in the Australian and New Zealand population. Nephrology Dialysis Transplantation. 2019;32(12):2127-31.

Chan S, Pascoe EM, Clayton PA, McDonald SP, Lim WH, Sypek MP, et al. Infection-related mortality in recipients of a kidney transplant in Australia and New Zealand. Clin J Am Soc Nephrol. 2019;14(10):1484-92.

Boudville N, Ullah S, Clayton P, Sud K, Borlace M, Badve SV, et al. Differences in peritoneal dialysis technique survival between patients treated with peritoneal dialysis systems from different companies. Nephrology Dialysis Transplantation. 2019;34(6):1035-44.

Zuvela J, Trimingham C, Le Leu R, Faull R, Clayton P, Jesudason S, et al. Gastrointestinal symptoms in patients receiving dialysis: A systematic review. Nephrology. 2018;23(8):718-27.

Ying T, Clayton P, Naresh C, Chadban S. Predictive value of spot versus 24-hour measures of proteinuria for death, end-stage kidney disease or chronic kidney disease progression. BMC Nephrology. 2018;19(1).

Trimingham C, McDonald S, Dansie K, Jesudason S, Faull R, Clayton P, et al. Bowel health in chronic kidney disease: Patient perceptions differ from clinical definitions. Journal of Renal Care. 2018;44(2):65-72.

Sypek MP, Clayton PA, Lim W, Hughes P, Kanellis J, Wright J, et al. Access to waitlisting for deceased donor kidney transplantation in Australia. Nephrology. 2018;24(7):758-66.

See E, Johnson D, Hawley C, Pascoe E, Badve S, Boudville N, et al. Risk Predictors and Causes of Technique Failure Within the First Year of Peritoneal Dialysis: An Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Study. Am J Kidney Dis. 2018;72(2):188-97.

Ritchie A, Clayton P, McDonald S, Kennedy S. Age-specific risk of renal graft loss from late acute rejection or non-compliance in the adolescent and young adult period. Nephrology. 2018;23(6):585-91.

Jegatheesan D, Johnson DW, Cho Y, Pascoe EM, Darssan D, Htay H, et al. The relationship between body mass index and organism-specific peritonitis. Perit Dial Int. 2018;38(3):206-14.

Htay H, Cho Y, Pascoe E, Darssan D, Nadeau-Fredette A, Hawley C, et al. Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry. Am J Kidney Dis. 2018;71(6):814-21.

Calisa V, Craig JC, Howard K, Howell M, Alexander S, Chadban SJ, et al. Survival and Quality of Life Impact of a Risk-based Allocation Algorithm for Deceased Donor Kidney Transplantation. Transplantation. 2018;102(9):1530-7.

Borlace M, Badve S, Sud K, Boudville N, McDonald S, Johnson D. Outcomes of acinetobacter peritonitis in peritoneal dialysis patients: a multicenter registry analysis. Perit Dial Int. 2018;38(4):257-65.

Aouad LJ, Clayton P, Wyburn KR, Gracey DM, Chadban SJ. Evolution of Glycemic Control and Variability after Kidney Transplant. Transplantation. 2018;102(9):1563-8.

Allen R, Pleass H, Woodroffe C, Clayton P, Ferrari P. Challenges of kidney paired donation transplants involving multiple donor and recipient surgeons across Australia. ANZ J Surg. 2018;88(3):167-71.

Zuvela J, Meade A, Trimingham C, Jesudason S, Leu RL. GASTROINTESTINAL SYMPTOMS IN PATIENTS RECEIVING DIALYSIS: A SYSTEMATIC REVIEW. Nephrology. 2017;22:82-.